Research Education Component (REC)

研究教育部分(REC)

基本信息

  • 批准号:
    10729792
  • 负责人:
  • 金额:
    $ 26.57万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2023
  • 资助国家:
    美国
  • 起止时间:
    2023-09-01 至 2028-06-30
  • 项目状态:
    未结题

项目摘要

The aim of the Research Education Component (REC) is to grow infrastructure and provide mentorship and pilot funding to early career investigators from underrepresented in medicine (UiM) backgrounds as delineated by NIH and this RFA (e.g., racial and ethnic minorities, women, first generation college students) who are interested in the developing, testing and implementing behavioral interventions for minority ADRD patients, care partners and dyads, following the revised NIH Stage Model, the Science of Behavior Change, the NIH Health Disparities Research Framework and the Center for Disease Prevention and National Academy of Medicine Prevention models. The REC will work closely with the Community Liaison and Recruitment Core (CLRC) and with the Massachusetts Alzheimer’s Disease Research Center (MADRC) and Boston University ADRC (BU-ADRC) RECs (both focused primarily on biomarkers) to allow for crosspollination of resources and knowledge including translating novel biological mechanisms into behavioral health intervention targets. The REC will support: 1) mentoring in ADRD and interdisciplinary behavioral research; 2) mentoring in health disparities, minority aging and community engaged research; 3) developing of a pilot studies program to support UiM early career investigators. Rates of ADRD are increasing drastically, with the greatest burden among minorities. Much of ADRD research has been focused on understanding the biology of disease, with less focus on behavioral health interventions for primary, secondary and tertiary prevention. Further, the burden of ADRD impacts not only the affected persons but also their informal care partners. There is a critical need for research to translate scientific advances into behavioral health interventions in both community and hospital settings to decrease ADRD burden for minority patients, care partners and dyads. The REC will directly address this need by leveraging: the interdisciplinary expertise at Massachusetts General Hospital (MGH), Boston Medical Center (BMC), Cambridge Health Alliance and affiliated clinics; the outstanding resources of Harvard and Boston University including MADRC, BU-ADRC; a NIA funded behavioral health ADRD R25; and numerous other important collaborators in the Boston area. The REC will also work closely to integrate activities and mentoring with other AD/ADRD RCMARs. The REC will be co-led by Ana-Maria Vranceanu (clinical psychologist) with expertise in behavioral health, ADRD, health disparities and community-engaged research, and a strong track record of mentoring, and Maureen O’Connor (clinical psychologist) who has expertise in ADRD and neuropsychology and leads the BU-ADRC REC. Specific aims are: 1) to develop and support a pilot project program (3 pilots/year; $40,000 each) from UiM investigators that fit the theme of the center; 2) to support the career development of pilot awardees (who will be named RCMAR Scientists) through a rigorous mentoring program; 3) to support mentoring of RCMAR Scientists in health disparities, ADRD and behavioral interventions following the NIH Stage Model, NIA Health Disparities Framework, and CDC and NAM prevention models; 4) to develop and implement an evaluation plan for aims 1, 2 and 3 in coordination with the Leadership and Administrative core of Massachusetts Center for Alzheimer and dEmeNtia behaVIoral reSearch In minOrity agiNg (Mass-ENVISION).
研究教育部分(REC)的目标是发展基础设施,并提供指导和试点资金 来自NIH和本RFA所描述的医学(UIM)背景的早期职业调查人员 (例如,种族和少数民族、女性、第一代大学生)对开发、测试 以及根据修订的NIH,对少数族裔ADRD患者、护理伙伴和双亲实施行为干预 阶段模型、行为改变科学、国立卫生研究院健康差异研究框架和疾病中心 预防和国家医学科学院预防模式。区域选举委员会将与社区联络处密切合作 与马萨诸塞州阿尔茨海默病研究中心(MADRC)和波士顿 大学ADRC(BU-ADRC)REC(两者都主要关注生物标记物),以允许资源和 知识,包括将新的生物机制转化为行为健康干预目标。区域经济合作委员会将 支持:1)在ADRD和跨学科行为研究方面提供指导;2)在健康差距、少数民族老龄化方面提供指导 和社区参与的研究;3)开发试点研究计划,以支持UIM早期职业调查人员。费率 ADRD的发病率急剧增加,少数族裔负担最重。ADRD的大部分研究都集中在 对疾病生物学的理解,较少关注初级、二级和初级行为健康干预 三级预防。此外,ADRD的负担不仅影响到受影响的人,也影响到他们的非正式护理伙伴。 在这两个社区,迫切需要研究将科学进步转化为行为健康干预 以及医院设置,以减轻少数族裔患者、护理伙伴和父母的ADRD负担。REC将直接解决 利用:马萨诸塞州综合医院(MGH)、波士顿医疗中心的跨学科专业知识 (BMC)、剑桥健康联盟及其附属诊所;哈佛大学和波士顿大学的杰出资源 包括MADRC、BU-ADRC;NIA资助的行为健康ADRD R25;以及许多其他重要的合作者 在波士顿地区。REC还将密切合作,将活动和指导与其他AD/ADRD RCMAR整合在一起。 REC将由Ana-Maria Vranceanu(临床心理学家)共同领导,拥有行为健康、ADRD、健康方面的专业知识 差异和社区参与的研究,以及良好的指导记录,以及Maureen O‘Connor(临床 心理学家),他在ADRD和神经心理学方面拥有专业知识,并领导BU-ADRC REC。具体目标是:1) 制定和支持UIM调查员的试点项目方案(3个试点/年;每人40,000美元),以符合 中心;2)支持飞行员获奖者(将被任命为RCMAR科学家)的职业发展 指导方案;3)支持RCMAR科学家在健康差距、ADRD和行为干预方面的指导 遵循NIH阶段模式、NIA健康差距框架以及CDC和NAM预防模式;4)开发 并与目标1、2和3的领导和行政核心协调执行目标1、2和3的评价计划 马萨诸塞州阿尔茨海默病和痴呆症少数民族老龄化行为研究中心(MASS-enVision)。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Ana-Maria Vranceanu其他文献

Ana-Maria Vranceanu的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Ana-Maria Vranceanu', 18)}}的其他基金

Mentoring in technology enhanced mind body and lifestyle interventions
技术指导增强身心和生活方式干预
  • 批准号:
    10553251
  • 财政年份:
    2022
  • 资助金额:
    $ 26.57万
  • 项目类别:
Mentoring in technology enhanced mind body and lifestyle interventions
技术指导增强身心和生活方式干预
  • 批准号:
    10347881
  • 财政年份:
    2022
  • 资助金额:
    $ 26.57万
  • 项目类别:
Recovering Together: Building resiliency in dyads of patients with an acute brain injury admitted to the Neuroscience Intensive Care Unit and their informal caregivers
共同康复:为神经科学重症监护室收治的急性脑损伤患者及其非正式护理人员建立复原力
  • 批准号:
    10463667
  • 财政年份:
    2021
  • 资助金额:
    $ 26.57万
  • 项目类别:
Recovering Together: Building resiliency in dyads of patients with an acute brain injury admitted to the Neuroscience Intensive Care Unit and their informal caregivers
共同康复:为神经科学重症监护室收治的急性脑损伤患者及其非正式护理人员建立复原力
  • 批准号:
    10273202
  • 财政年份:
    2021
  • 资助金额:
    $ 26.57万
  • 项目类别:
Recovering Together: Building resiliency in dyads of patients with an acute brain injury admitted to the Neuroscience Intensive Care Unit and their informal caregivers
共同康复:为神经科学重症监护室收治的急性脑损伤患者及其非正式护理人员建立复原力
  • 批准号:
    10618995
  • 财政年份:
    2021
  • 资助金额:
    $ 26.57万
  • 项目类别:
Toolkit for Optimal Recovery after Orthopedic Injury; A multi-site feasibility study to prevent persistent pain and disability
骨科损伤后最佳恢复工具包;
  • 批准号:
    10403955
  • 财政年份:
    2020
  • 资助金额:
    $ 26.57万
  • 项目类别:
Toolkit for Optimal Recovery after Orthopedic Injury; A multi-site feasibility study to prevent persistent pain and disability
骨科损伤后最佳恢复工具包;
  • 批准号:
    10596395
  • 财政年份:
    2020
  • 资助金额:
    $ 26.57万
  • 项目类别:
Toolkit for Optimal Recovery after Orthopedic Injury; A multi-site feasibility study to prevent persistent pain and disability
骨科损伤后最佳恢复工具包;
  • 批准号:
    10622581
  • 财政年份:
    2020
  • 资助金额:
    $ 26.57万
  • 项目类别:
Toolkit for Optimal Recovery after Orthopedic Injury; A multi-site feasibility study to prevent persistent pain and disability
骨科损伤后最佳恢复工具包;
  • 批准号:
    10918399
  • 财政年份:
    2020
  • 资助金额:
    $ 26.57万
  • 项目类别:
Recovering Together: Building resiliency in dyads of patients admitted to the Neuroscience Intensive Care Unit (NICU) and their caregivers
共同康复:为入住神经科学重症监护病房 (NICU) 的患者及其护理人员建立复原力
  • 批准号:
    9794134
  • 财政年份:
    2018
  • 资助金额:
    $ 26.57万
  • 项目类别:

相似海外基金

Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
  • 批准号:
    MR/S03398X/2
  • 财政年份:
    2024
  • 资助金额:
    $ 26.57万
  • 项目类别:
    Fellowship
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
  • 批准号:
    2338423
  • 财政年份:
    2024
  • 资助金额:
    $ 26.57万
  • 项目类别:
    Continuing Grant
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
  • 批准号:
    EP/Y001486/1
  • 财政年份:
    2024
  • 资助金额:
    $ 26.57万
  • 项目类别:
    Research Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
  • 批准号:
    MR/X03657X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 26.57万
  • 项目类别:
    Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
  • 批准号:
    2348066
  • 财政年份:
    2024
  • 资助金额:
    $ 26.57万
  • 项目类别:
    Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
  • 批准号:
    AH/Z505481/1
  • 财政年份:
    2024
  • 资助金额:
    $ 26.57万
  • 项目类别:
    Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 26.57万
  • 项目类别:
    EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
  • 批准号:
    2341402
  • 财政年份:
    2024
  • 资助金额:
    $ 26.57万
  • 项目类别:
    Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 26.57万
  • 项目类别:
    EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
  • 批准号:
    AH/Z505341/1
  • 财政年份:
    2024
  • 资助金额:
    $ 26.57万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了